These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22938401)

  • 1. Metastasis-associated factors facilitating the progression of colorectal cancer.
    Zhang YY; Chen B; Ding YQ
    Asian Pac J Cancer Prev; 2012; 13(6):2437-44. PubMed ID: 22938401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer].
    Wideł MS; Wideł M
    Postepy Hig Med Dosw (Online); 2006; 60():453-70. PubMed ID: 17013365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extracellular matrix degradation enzymes: important factors in liver metastasis of colorectal cancer and good targets for anticancer metastatic therapy].
    Ichikawa Y; Ishikawa T; Tanaka K; Togo S; Shimada H
    Nihon Geka Gakkai Zasshi; 2001 May; 102(5):376-80. PubMed ID: 11393999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The urokinase-type plasminogen activator system and its role in tumor progression].
    Kugaevskaya EV; Gureeva TA; Timoshenko OS; Solovyeva NI
    Biomed Khim; 2018 Nov; 64(6):472-486. PubMed ID: 30632975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.
    Mauro CD; Pesapane A; Formisano L; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Monteleone F; Zambrano N; Fontanini G; Servadio A; Pignataro G; Grumetto L; Lavecchia A; Bruzzese D; Iaccarino A; Troncone G; Veneziani BM; Montuori N; Placido S; Bianco R
    Sci Rep; 2017 Aug; 7(1):9388. PubMed ID: 28839232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases in colorectal cancer.
    Mysliwiec AG; Ornstein DL
    Clin Colorectal Cancer; 2002 Feb; 1(4):208-19. PubMed ID: 12450419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms in development of colorectal cancer metastasis].
    Bognár G; Ledniczky G; István G; Ondrejka P
    Magy Seb; 2006 Oct; 59(5):342-9. PubMed ID: 17201342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.
    Santibanez JF; Obradović H; Kukolj T; Krstić J
    Dev Dyn; 2018 Mar; 247(3):382-395. PubMed ID: 28722327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Matrix metalloproteinases and colorectal cancer].
    Roeb E; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis.
    Saito K; Takeha S; Shiba K; Matsuno S; Sorsa T; Nagura H; Ohtani H
    Int J Cancer; 2000 Apr; 86(1):24-9. PubMed ID: 10728590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma].
    Jung SA; Yang SK; Kim JS; Shim KN; Im SA; Myung SJ; Jung HY; Yu CS; Kim JC; Hong WS; Kim JH; Min YI
    Korean J Gastroenterol; 2005 Jun; 45(6):401-8. PubMed ID: 15973074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of hepatic metastasis in colorectal cancer.
    Rudmik LR; Magliocco AM
    J Surg Oncol; 2005 Dec; 92(4):347-59. PubMed ID: 16299807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular mechanism of liver metastasis from colorectal cancer].
    Fang YJ; Wan DS
    Ai Zheng; 2008 May; 27(5):549-54. PubMed ID: 18479609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
    Leeman MF; Curran S; Murray GI
    J Pathol; 2003 Dec; 201(4):528-34. PubMed ID: 14648655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development].
    Groblewska M; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2010 Jan; 64():22-30. PubMed ID: 20173217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and cancer - roles in threat and therapy.
    Yadav L; Puri N; Rastogi V; Satpute P; Ahmad R; Kaur G
    Asian Pac J Cancer Prev; 2014; 15(3):1085-91. PubMed ID: 24606423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer: targeting metastasis and angiogenesis.
    Chu E
    Clin Colorectal Cancer; 2002 Feb; 1(4):200. PubMed ID: 12450417
    [No Abstract]   [Full Text] [Related]  

  • 18. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis.
    Yoon SO; Park SJ; Yun CH; Chung AS
    J Biochem Mol Biol; 2003 Jan; 36(1):128-37. PubMed ID: 12542983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
    Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
    Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-surface GRP78 facilitates colorectal cancer cell migration and invasion.
    Li Z; Zhang L; Zhao Y; Li H; Xiao H; Fu R; Zhao C; Wu H; Li Z
    Int J Biochem Cell Biol; 2013 May; 45(5):987-94. PubMed ID: 23485528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.